Literature DB >> 8448585

Allopurinol and amlodipine improve coronary vasodilatation after myocardial ischaemia and reperfusion in anaesthetized dogs.

C G Sobey1, R A Dalipram, O L Woodman.   

Abstract

1. We have assessed the effect of allopurinol, amlodipine and propranolol pretreatment on both endothelium-dependent and endothelium-independent coronary vasodilatation in vivo, by comparing pre-ischaemic responses with those measured after 60 min of coronary artery occlusion and 30 min of reperfusion in anaesthetized dogs. 2. In 15 untreated dogs ischaemia and reperfusion attenuated the increases in coronary blood flow produced by either acetylcholine (0.01-0.05 micrograms kg-1, i.a.) or glyceryl trinitrate (0.05-0.2 micrograms kg-1, i.a.), to an average of 39 +/- 4% and 42 +/- 5% of the pre-ischaemic control response, respectively (both P < 0.05). 3. In 5 dogs treated with allopurinol (25 mg kg-1, orally, 24 h previously, plus 50 mg kg-1, i.v., 5 min before occlusion), the increases in coronary blood flow after ischaemia and reperfusion (acetylcholine: 78 +/- 12%, glyceryl trinitrate: 60 +/- 3% of pre-ischaemic response) were significantly larger than post-ischaemic responses in untreated dogs (both P < 0.05). 4. Similarly, amlodipine treatment (3 micrograms kg-1 min-1, i.v., starting 90 min before occlusion) in 5 dogs improved post-ischaemic increases in blood flow (acetylcholine: 58.5%, glyceryl trinitrate: 66 +/- 6% of pre-ischaemic response, significantly greater than post-ischaemic responses in untreated dogs, P < 0.05). 5. In contrast, in a further 6 dogs pretreated with propranolol (1 mg kg-1, i.v., 30 min before occlusion,plus 0.5 mg kg-1 h-1, i.v.), blood flow responses after ischaemia and reperfusion were not different from post-ischaemic responses in untreated dogs (acetylcholine: 46 +/- 6%, glyceryl trinitrate: 46 +/-6% of pre-ischaemic response).6. These results suggest that allopurinol and amlodipine protect against the post-ischaemic impairment of endothelium-dependent and endothelium-independent coronary vasodilatation in vivo by mechanisms additional to endothelial protection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448585      PMCID: PMC1907964          DOI: 10.1111/j.1476-5381.1993.tb12807.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium.

Authors:  W G Nayler; R Ferrari; A Williams
Journal:  Am J Cardiol       Date:  1980-08       Impact factor: 2.778

2.  Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro.

Authors:  K M VanBenthuysen; I F McMurtry; L D Horwitz
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

3.  Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).

Authors:  B R Lucchesi; W E Burmeister; T E Lomas; G D Abrams
Journal:  J Pharmacol Exp Ther       Date:  1976-11       Impact factor: 4.030

4.  Impaired endothelium-dependent relaxation of dog coronary arteries after myocardial ischaemia and reperfusion: prevention by amlodipine, propranolol and allopurinol.

Authors:  C G Sobey; R A Dalipram; G J Dusting; O L Woodman
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

5.  Role of leukocytes in coronary vascular endothelial injury due to ischemia and reperfusion.

Authors:  F M Sheridan; I M Dauber; I F McMurtry; E J Lesnefsky; L D Horwitz
Journal:  Circ Res       Date:  1991-12       Impact factor: 17.367

6.  Cardioprotective and endothelial protective effects of [Ala-IL8]77 in a rabbit model of myocardial ischaemia and reperfusion.

Authors:  A M Lefer; G Johnson; X L Ma; P S Tsao; G R Thomas
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

7.  Nifedipine reduces the incidence of myocardial infarction and transient ischemia in patients undergoing coronary bypass grafting.

Authors:  R Seitelberger; W Zwölfer; S Huber; S Schwarzacher; T M Binder; F Peschl; J Spatt; C Holzinger; B Podesser; P Buxbaum
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

8.  Ischemia-induced epicardial vasoconstriction. A potential mechanism for distant myocardial ischemia.

Authors:  A Chu; D E Chambers; C C Lin; W D Kuehl; F R Cobb
Journal:  Circ Res       Date:  1990-06       Impact factor: 17.367

9.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

10.  Coronary vascular reactivity after acute myocardial ischemia.

Authors:  D D Ku
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

View more
  4 in total

1.  Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure.

Authors:  S D Anker; F Leyva; P A Poole-Wilson; W J Kox; J C Stevenson; A J Coats
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

Review 2.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

Review 3.  Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease.

Authors:  M Haria; A J Wagstaff
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

4.  Oxidation by trace Cu2+ ions underlies the ability of ascorbate to induce vascular dysfunction in the rat perfused mesentery.

Authors:  Silvia Nelli; John Craig; William Martin
Journal:  Eur J Pharmacol       Date:  2009-04-24       Impact factor: 4.432

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.